Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.
- Published in:
- Medicinal Research Reviews, 2017, v. 37, n. 2, p. 368, doi. 10.1002/med.21410
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2017 AND VI 37 AND IP 2
Results: 6
1
2
Issue Information - TOC.
- Published in:
- Medicinal Research Reviews, 2017, v. 37, n. 2, p. 217, doi. 10.1002/med.21412
- Publication type:
- Article
3
Topoisomerases: Resistance versus Sensitivity, How Far We Can Go?
- Published in:
- Medicinal Research Reviews, 2017, v. 37, n. 2, p. 404, doi. 10.1002/med.21417
- By:
- Publication type:
- Article
4
Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities.
- Published in:
- Medicinal Research Reviews, 2017, v. 37, n. 2, p. 219, doi. 10.1002/med.21407
- By:
- Publication type:
- Article
5
The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.
- Published in:
- Medicinal Research Reviews, 2017, v. 37, n. 2, p. 271, doi. 10.1002/med.21408
- By:
- Publication type:
- Article
6
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.
- Published in:
- Medicinal Research Reviews, 2017, v. 37, n. 2, p. 314, doi. 10.1002/med.21409
- By:
- Publication type:
- Article